|Day Low/High||3.39 / 3.55|
|52 Wk Low/High||1.03 / 9.40|
The market has strengthened a bit since our last update. T2 Biosystems is now up over 50% on positive developments that we chronicled in my last post. Lexicon Pharmaceuticals is up some 30% today off oversold levels. It should receive some $260 mil...
Here's why to check out Dynavax Technologies as well Lexicon, Supernus and Acadia Pharmaceuticals.
We have a few more days of this slow trading, and it is unlikely to change much.
Signs of support on the S&P, but there is a lot of uncertainty.
But bears finally have some momentum heading into a seasonally poor month.
Lexicon Pharmaceuticals (LXRX) shares are up nearly 50% since it announced Monday that its carcinoid syndrome drug telotristat etiprate met its primary endpoint in a late stage clinical trial.